ILMN

Illumina
D

ILMN

141.305
USD
4.68
(3.43%)
Market Closed
Volume
0
EPS
4
Div Yield
-
P/E
-14
Market Cap
22,410,973,000
OverviewSignalsIdeasNews
Related Instruments
    ABT
    ABT
    3.320
    (2.93%)
    116.810 USD
    A
    ALGN
    3.660
    (1.63%)
    228.000 USD
    AMGN
    AMGN
    2.60
    (0.96%)
    274.85 USD
    BDX
    BDX
    2.920
    (1.23%)
    240.260 USD
    B
    BMRN
    0.920
    (1.49%)
    62.490 USD
    DHR
    DHR
    5.750
    (2.41%)
    244.110 USD
    GILD
    GILD
    1.160
    (1.26%)
    92.950 USD
    L
    LH
    5.130
    (2.15%)
    244.000 USD
    REGN
    REGN
    5.83
    (0.86%)
    687.32 USD
    TMO
    TMO
    13.24
    (2.36%)
    572.91 USD
    More
News

Title: Illumina

Sector: Healthcare
Industry: Diagnostics & Research
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2023 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Trading. Social. Simple.
FacebookTwitterYoutube
Company
Contact usAbout usTerms Of UsePrivacy PolicyCookies PolicyDisclaimerHelp Center
Social Network
The NetworkSignals NetworkIdeas NetworkBest Traders
Products
Risk CalculatorPip CalculatorAdvance Chart
Markets
Exchange RatesCommodities RatesCryptocurrencies RatesIndices RatesUS Stocks Rates
Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.